OKYO Pharma Ltd. Form 6-K Summary
Business Context and Reporting Period
OKYO Pharma Ltd. furnished this Form 6-K on December 1, 2022. The filing reports a corporate governance and reporting matter rather than periodic financial results. The company files annual reports on Form 20-F.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.
Material Changes
OKYO Pharma announced a change of auditor. The filing incorporates a December 1, 2022 news announcement as Exhibit 99.1, but the text provided does not identify the outgoing or incoming auditor or provide the reasons, effective date, or other terms of the change.
Guidance, Outlook, Risks, and Unusual Items
No guidance, outlook, management commentary, operating risks, contingencies, or unusual financial items are disclosed in the available filing text.
Investor Verification Items
- Verify the full content of Exhibit 99.1 and identify the former and successor auditors.
- Determine the reason for, effective date of, and any disagreements or reportable events associated with the auditor change.
- Review the company’s latest Form 20-F and subsequent filings for financial results, liquidity, financing needs, and audit status.